US Stock Details

Get in-depth insights on US stocks, including fundamentals, financials, shareholding, peer comparison, and performance. Track key metrics, price trends, and market sentiment for informed decisions. Stay ahead with expert analysis and data-driven strategies at Motilal Oswal.

CLEARPOINT NEURO INC

us-stock
To Invest in {{usstockname}}
us-stock
$14.07 0.0555(5.55%) CLPT at 04 Dec 2025 04:28 PM Medical Devices
Lowest Today 13.11
Highest Today 14.135
Today’s Open 13.25
Prev. Close 13.34
52 Week High 30.10
52 Week Low 9.76
Day’s Range: Low 13.11 High 14.135
52-Week Range: Low 9.76 High 30.10
1 day return -
1 Week return -2.15
1 month return -19.57
3 month return +27.16
6 month return +8.55
1 year return +10.59
3 year return +48.62
5 year return +42.9
10 year return -

Institutional Holdings

BlackRock Inc 6.10

Vanguard Group Inc 5.19

Vanguard Total Stock Mkt Idx Inv 2.84

iShares Russell 2000 ETF 2.24

Geode Capital Management, LLC 2.20

Rolnik Focus FIL 1.76

State Street Corp 1.17

Morgan Stanley - Brokerage Accounts 1.17

Brown Advisory Holdings Inc 1.16

Essex Investment Management Company, LLC 1.14

Vanguard Institutional Extnd Mkt Idx Tr 1.04

D. E. Shaw & Co LP 1.02

Goldman Sachs Group Inc 1.01

Fidelity Small Cap Index 0.92

Lane Generational LLC 0.91

Financial Engines Advisors L.l.c. 0.88

Cahill Wealth Management, LLC 0.86

iShares Russell 2000 Growth ETF 0.80

Northern Trust Corp 0.72

CM Management, LLC 0.70

Taylor Frigon Capital Management LLC 0.63

Conway Capital Management Inc 0.58

UBS Group AG 0.55

Parsons Capital Management Inc 0.50

Fidelity Extended Market Index 0.50

Vanguard Russell 2000 ETF 0.44

Bank of America Corp 0.40

Millennium Management LLC 0.35

State St Russell Sm Cap® Indx SL Cl I 0.32

1290 Essex Small Cap Growth I 0.26

Bridgeway Ultra-Small Company 0.24

Schwab Small Cap Index 0.23

NT R2000 Index Fund - NL 0.22

iShares Micro-Cap ETF 0.21

Extended Equity Market Fund K 0.19

NT R2000 Index Fund - DC - NL - 3 0.18

Fidelity Total Market Index 0.17

Taylor Frigon Core Growth 0.16

Pleiades Small Cap Equity A 0.16

iShares Russell 2000 Small-Cap Idx Instl 0.16

Market Status

Strong Buy: 2

Buy: 0

Hold: 0

Sell: 0

Strong Sell: 0

Fundamentals

Market Cap 396.84 M

PB Ratio 27.0984

PE Ratio 0.0

Enterprise Value 427.68 M

Total Assets 39.19 M

Volume 638438

Company Financials

Annual Revenue FY24:31390000 31.4M, FY23:22319000 22.3M, FY22:20551000 20.6M, FY21:16299000 16.3M, FY20:12829000 12.8M

Annual Profit FY24:19122000 19.1M, FY23:12967000 13.0M, FY22:13531000 13.5M, FY21:11291000 11.3M, FY20:9120000 9.1M

Annual Net worth FY24:-18914000 -18.9M, FY23:-21855000 -21.9M, FY22:-16538000 -16.5M, FY21:-15320000 -15.3M, FY20:-9108000 -9.1M

Quarterly Revenue Q3/2025:8861000 8.9M, Q2/2025:9215000 9.2M, Q1/2025:8485000 8.5M, Q3/2024:8122000 8.1M, Q2/2024:7858000 7.9M

Quarterly Profit Q3/2025:5600000 5.6M, Q2/2025:5556000 5.6M, Q1/2025:5132000 5.1M, Q3/2024:4847000 4.8M, Q2/2024:4988000 5.0M

Quarterly Net worth Q3/2025:-5891000 -5.9M, Q2/2025:-5837000 -5.8M, Q1/2025:-6026000 -6.0M, Q3/2024:-4974000 -5.0M, Q2/2024:-4408000 -4.4M

Fund house & investment objective

Company Information ClearPoint Neuro, Inc. operates as a medical device company primarily in the United States. It develops and commercializes platforms for performing minimally invasive surgical procedures in the brain under magnetic resonance imaging guided interventions. The company offers ClearPoint system, an integrated system for the insertion of deep brain stimulation electrodes, biopsy needles, and laser catheters, as well as the infusion of pharmaceuticals into the brain. It has license and collaboration agreement with Clinical Laserthermia Systems AB; license and research agreement with Koninklijke Philips N.V.; UCB Biopharma SRL; NE Scientific, LLC; and University of California, San Francisco, and Johns Hopkins University. The company was formerly known as MRI Interventions, Inc. and changed its name to ClearPoint Neuro, Inc. in February 2020. ClearPoint Neuro, Inc. was incorporated in 1998 and is headquartered in Solana Beach, California.

Organisation Medical Devices

Employees 115

Industry Medical Devices

CEO Mr. Joseph Michael Burnett

Trading and brokerage services provided by

Technology Services provided by Motilal Oswal Financial Services:

Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*

Take your next step

Talk to our investment advisor for stock recommendations
Left
Get expert assistance for portfolio management
Right